Meanwhile, the guidance also calls for type 2 diabetes with cardiovascular disease to be offered triple therapy that includes a GLP-1 agonist, while people diagnosed at an early age below 40 should get dual therapy "before a GLP-1 receptor agonist is considered." All told, the expectation is that around 750,000 more people with type 2 diabetes could be offered GLP-1 drugs if the guidance is accepted in its current form
Both soluble and insoluble fiber are helpful
Ghrelin mimetics like ipamorelin bind a separate receptor, the ghrelin receptor, and act through a different intracellular pathway
GLP-1 receptor agonists (GLP-1RAs) are used for glycemic control in diabetes and show potential neuroprotective properties, but their effects on AD and the underlying mechanisms are not well understood
This article covers the differences between Ozempic and Zepbound to help you understand their unique mechanism of action, guidelines for switching between these medications, potential side effects, and other important details
Many patients combine both approaches for broader wellness support plus targeted skin benefits